NCT00867529 2018-01-02Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaFred Hutchinson Cancer CenterPhase 2 Completed63 enrolled 12 charts